Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
After finishing at $17.49 in the prior trading day, Adma Biologics Inc (NASDAQ: ADMA) closed at $17.15, down -1.94%. In other words, the price has decreased by -$1.94 from its previous closing price. On the day, 1.77 million shares were traded. ADMA stock price reached its highest trading level at $17.75 during the session, while it also had its lowest trading level at $16.96.
Ratios:
Our goal is to gain a better understanding of ADMA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 45.85 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 50.07. For the most recent quarter (mrq), Quick Ratio is recorded 3.26 and its Current Ratio is at 7.09. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.48.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 22 ’24 when Tade Brad L. sold 15,000 shares for $21.15 per share. The transaction valued at 317,250 led to the insider holds 199,433 shares of the business.
Grossman Adam S sold 48,967 shares of ADMA for $1,033,204 on Nov 22 ’24. The President and CEO now owns 1,989,007 shares after completing the transaction at $21.10 per share. On Nov 22 ’24, another insider, Grossman Adam S, who serves as the Director and Officer of the company, bought 48,967 shares for $21.30 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 4054088448 and an Enterprise Value of 4078769920. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 62.07, and their Forward P/E ratio for the next fiscal year is 23.57. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.96. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.38 while its Price-to-Book (P/B) ratio in mrq is 17.48. Its current Enterprise Value per Revenue stands at 10.655 whereas that against EBITDA is 32.398.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $23.64, while it has fallen to a 52-week low of $4.37. The 50-Day Moving Average of the stock is -9.57%, while the 200-Day Moving Average is calculated to be 23.16%.
Shares Statistics:
The stock has traded on average 3.61M shares per day over the past 3-months and 2353700 shares per day over the last 10 days, according to various share statistics. A total of 236.38M shares are outstanding, with a floating share count of 228.48M. Insiders hold about 3.35% of the company’s shares, while institutions hold 88.41% stake in the company. Shares short for ADMA as of 1734048000 were 12177527 with a Short Ratio of 3.38, compared to 1731628800 on 14239500. Therefore, it implies a Short% of Shares Outstanding of 12177527 and a Short% of Float of 5.3000003.
